- Kallistatin inhibits lymphangiogenesis and lymphatic metastasis of gastric cancer by downregulating VEGF-C expression and secretion
Caiqi Ma et al, 2018, Gastric Cancer CrossRef - The potential role of kallistatin as a new biomarker in non-invasive diagnostics of non-alcoholic fatty liver disease with hypertension
null null et al, 2019, Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini CrossRef - Phomaketide A Inhibits Lymphangiogenesis in Human Lymphatic Endothelial Cells
Huai-Ching Tai et al, 2019, Marine Drugs CrossRef - Advances in Drugs Targeting Lymphangiogenesis for Preventing Tumor Progression and Metastasis
Chuqi Wang et al, 2022, Frontiers in Oncology CrossRef - Angiogenesis and Lymphangiogenesis in Peritoneal Dialysis
Guadalupe Tirma Gónzalez-Mateo et al, 2018, Aspects in Dialysis CrossRef - Stromal cells in breast cancer as a potential therapeutic target
Samantha S. Dykes et al, 2018, Oncotarget CrossRef - PEDF inhibits lymphatic metastasis of nasopharyngeal carcinoma as a new lymphangiogenesis inhibitor
Chuanghua Luo et al, 2021, Cell Death & Disease CrossRef - Kallistatin prevents ovarian hyperstimulation syndrome by regulating vascular leakage
Jianfang Huang et al, 2022, Journal of Cellular and Molecular Medicine CrossRef - Kallistatin Deficiency Induces the Oxidative Stress-Related Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells: A Novel Protagonist in Age-Related Macular Degeneration
Gang Shen et al, 2023, Investigative Opthalmology & Visual Science CrossRef